Angiodynamics (ANGO) Share-based Compensation (2010 - 2026)

Angiodynamics (ANGO) has 17 years of Share-based Compensation data on file, last reported at $2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 11.93% year-over-year to $2.7 million; the trailing twelve-month figure through Feb 2026 stood at $11.7 million (up 16.55% YoY), and the FY2025 full-year result was $9.8 million, down 7.19% from the prior year.
• Share-based Compensation for Q1 2026 stood at $2.7 million, down from $2.9 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $4.5 million in Q3 2025 and bottomed at $1.6 million in Q2 2025.
• The 5-year median for Share-based Compensation is $2.7 million (2026), against an average of $2.8 million.
• The widest annual swing landed in 2023, when Share-based Compensation sank 43.97%; it then jumped 44.87% in 2024.
• A 5-year view of Share-based Compensation shows it stood at $3.4 million in 2022, then plunged by 43.97% to $1.9 million in 2023, then soared by 34.68% to $2.5 million in 2024, then advanced by 14.36% to $2.9 million in 2025, then retreated by 7.16% to $2.7 million in 2026.
• The last three Share-based Compensation figures came in at $2.7 million (Q1 2026), $2.9 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.

Peer Comparison